LOINC Code 21869-3: Hospital admission.first contact [Date and time] Cancer
21869-3 is a LOINC code used to identify Hospital admission.first contact [Date and time] Cancer in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Hospital admission.first contact. It is commonly used with the system or sample type Cancer.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Hospital admission.first contact. It is commonly used with the system or sample type Cancer.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Hospital admission.first contact [Date and time] Cancer
- Hospital admission.first contact
- Date of first patient contact, as inpatient or outpatient, with the reporting facility for the diagnosis and/or treatment of the tumor. The date may represent the date of an outpatient visit for a biopsy, x-ray, scan, or laboratory test. See page 81 for date format. When Pathology Specimen Only (Class of Case 7, Type of Reporting Source 3) tumors are collected, the Path--Date of Specimen Collection [7320] from the pathology report should be used for the Date of 1st Contact. If a pathology-specimen-only case is followed by a patient contact with the facility for the diagnosis and/or treatment of the respective tumor, the Date of 1st Contact is not changed. The date of the initial pathology laboratory specimen collection remains the Date of 1st Contact. When Death Certificate Only (Class of Case 8, Type of Reporting Source 7) tumors are collected, the date of death should be used as the Date of 1st Contact. When Autopsy Only (Class of Case 5, Type of Reporting Source 6) tumors are collected, the date of death should be used as the Date of 1st Contact. Timeliness of abstracting (and reporting) is a concern for all standard-setting organizations. Date of 1st Contact is one of several data items that can be used to measure timeliness of reporting by individual facilities to central cancer registries. For tumors that are not diagnosed at the reporting facility (Class of Case 2, 3, or 4), the Date of 1st Contact [580] can be used in conjunction with the Date Case Report Received [2111] to measure timeliness of reporting by individual facilities. To accurately measure the timeliness of data collection and submission of abstracts that are first diagnosed at autopsy (Class of Case 5, Type of Reporting Source 6) the date of death should be used as the Date of 1st Contact since the diagnosis was not determined until the autopsy was performed. Death Certificate Only cases (Class of Case 8, Type of Reporting Source 7) are created only by the central registry. For these cases, Date of 1st Contact should be filled with the date of death, and timeliness for DCO cases should be measured by different criteria... NAACCR Data Standards and Data Dictionary Version 11
- CA; Date and time; Hosp; Hosp adm 1st contact; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp; TUMOR REGISTRY(NAACCR)
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.